Alexandra Stefanovic, MD
Hematologic Oncologist, Hematologist (Malignant)
My Locations
Part of the Duke Cancer Institute
Part of the Duke Cancer Institute
About Me
I am convinced that caring for patients with malignant hematologic diseases requires not only up-to-date medical knowledge, but also an understanding of the individual patient's needs and circumstances. I encourage patients to take an active role in their treatment and recovery and I work with them to develop an individualized treatment plan that includes the most advanced therapies available today. My practice focuses primarily on disorders of the lymphatic system (Hodgkin and non-Hodgkin lymphoma and chronic lymphocytic leukemia). As an integral part of my clinical activities, I am dedicated to teaching young physicians at all levels of training and educating the next generation of hematologists.
LGBTQ+ Identified or Ally
- Associate Professor of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy 2021
Call for an Appointment
Areas of Expertise
- Lymphoma
- Hodgkin Lymphoma
- Non-Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Waldenstrom's Macroglobulinemia
Ratings and Reviews
The ratings and reviews are based on patient responses to the overall provider rating question from the survey. The question reads: “Using any number from 0 to 10, where 0 is the worst provider possible and 10 is the best provider possible, what number would you use to rate this provider?” Responses are converted to a 5-point rating system and applied consistently to all providers. Learn more about our survey process. Patients who see some types of providers receive a different version of the patient satisfaction survey. Those results are not available on DukeHealth.org.
Training and Education
Clinical Focus and Research
My research focuses on lymphomas and related disorders through clinical trials and collaborative research projects. It is my goal to provide patients, whenever possible, access to carefully selected clinical trials with novel therapies that may help them live longer or improve their quality of life.
- Belina, M. E., A. K. Brys, M. R. Ramirez, R. N. Al-Rohil, N. J. Chao, A. Stefanovic, and A. R. Cardones. “Cutaneous Vasculopathy and Recalcitrant Lower-Extremity Ulcerations.” Annals of Internal Medicine Clinical Cases 2, no. 4 (April 1, 2023). https://doi.org/10.7326/aimcc.2022.0334.
- Alderuccio, Juan Pablo, Luca Arcaini, Marcus P. Watkins, Anne W. Beaven, Geoffrey Shouse, Narendranath Epperla, Michele Spina, et al. “An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma.” Blood Adv 6, no. 7 (April 12, 2022): 2035–44. https://doi.org/10.1182/bloodadvances.2021006844.
- Wonnaparhown, Alex, Alexandra Stefanovic, Patricia Lugar, and Haley P. Hostetler. “Acquired angioedema in B cell lymphoproliferative disease: A retrospective case series.” Clin Exp Immunol 206, no. 3 (December 2021): 378–83. https://doi.org/10.1111/cei.13667.
- Sainvil, Marie Michele, Melissa Lowe, Delaney Underwood, Yan Li, Tomi F. Akinyemiju, Taewoong Choi, Cristina Gasparetto, et al. “Disparities in CAR-T Therapy Access and Outcomes: Variation in Referral Patterns for CAR-T Therapy in Patients with Newly Diagnosed Malignancies at an Academic Center in North Carolina.” In Blood, 144:5044–5044. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-211637.
- Alderuccio, Juan Pablo, Anne W. Beaven, Geoffrey Shouse, Narendranath Epperla, Alexandra Stefanovic, Pallawi Torka, Jorge J. Castillo, et al. “Frontline Bendamustine and Rituximab in Extranodal Marginal Zone Lymphoma: An International Analysis.” In Blood, 136:2–3. American Society of Hematology, 2020. https://doi.org/10.1182/blood-2020-137620.
- Saul, Eduardo Edelman, Amrita Desai, Jennifer Chapman, Lazaros J. Lekakis, Alexandra Stefanovic, and Agustin Pimentel. “Adult lymphoma-associated hemophagocytic lymphohistiocytosis: A clinical case series in a predominantly Hispanic cohort from the University of Miami/Jackson Memorial Hospital.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.
Insurance Accepted
Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below.
-
Aetna
- Aetna Choice POS, Aetna Choice POS II
- Aetna Elect Choice HMO, Aetna Open Access Elect Choice
- Aetna Health Network Only, Aetna Health Network Option
- Aetna HMO
- Aetna Limited Benefit Insurance PPO
- Aetna Managed Choice POS
- Aetna Medicare Assure Plan (HMO D-SNP)
- Aetna Medicare Eagle Plan (PPO)
- Aetna Medicare Essential Plan (PPO)
- Aetna Medicare Value Plan (HMO)
- Aetna Open Access HMO, Open Access Aetna Select, Aetna Open Access Managed Choice
- Aetna Open Choice PPO
- Aetna PCP Coordinated POS Plan
- Aetna Quality Point of Service (QPOS)
- Aetna Select HMO
- Aetna Traditional Choice
- Aetna Voluntary Indemnity Group Plan
- Aetna Whole Health – Duke WakeMed WKCC
- Aetna/CVS Health
-
Ambetter
- Ambetter of North Carolina
-
Blue Cross Blue Shield of NC
- Blue Advantage
- Blue Medicare (HMO, PPO)*
- Blue Options (123, PPO, HSA)
- Blue Select
- NC State Employees Health Plan
-
*Duke HomeCare and Hospice does not participate in the plan.
-
Cigna
- Cigna Behavioral Health (*Limited eligibility)
- Cigna Choice Plus
- Cigna Connect Individual Family Plan
- Cigna Open Access
- Cigna Open Access Plus
-
*Please call Cigna Behavioral Heath to see if the provider is participating in your plan.
-
Duke Group Plans
- Duke Basic
- Duke Select
-
Experience Health
- Experience Health Medicare Advantage (HMO) Plan
- Gateway Health Alliance
- Healthgram
-
Humana
- Humana Choice (PPO)
- Humana Choice - Medicare Advantage (PPO)
- Humana ChoiceCare - Medicare Advantage (PPO)
- Humana Gold Choice - Medicare Advantage (PFFS)
- Humana Gold Plus - Medicare Advantage (HMO)
- Humana Medicare Advantage Group Plan - NC State Retirees
- MedCost
-
Medicare
- First Medicare Direct
- Medicare Part A
- Medicare Part B
-
NC Medicaid
- AmeriHealth Caritas North Carolina
- Carolina Complete Health
- Healthy Blue
- NC Medicaid Direct
- WellCare of North Carolina
-
TRICARE
- TRICARE Prime
- TRICARE Prime Remote
- TRICARE Select
-
United Healthcare
- AARP Medicare Advantage Plan 2 (HMO-POS)
- AARP Medicare Complete (HMO, PPO)*
- AARP Medicare Complete Essential (HMO)*
- All Savers Alternate Funding
- All Savers Fully Insured
- United Healthcare (HMO, PPO, POS)**
- United Healthcare Charter/Charter Balance/Charter Plus
- United Healthcare Choice/Choice Plus
- United Healthcare Core/Core Essential
- United Healthcare Navigate/Navigate Plus/Navigate Balanced
- United Healthcare Option PPO
- United Healthcare Passport Connect Choice/Choice Plus
- United Healthcare Passport Connect Options PPO
- United Healthcare Select/Select Plus
- United Healthcare Shared Services - Harvard Pilgrim/UHC Options PPO Network
- United Medical Resources (UMR)
-
*Duke HomeCare and Hospice and mental health providers do not participate with the plan.
-
**Duke Health does not participate in UHC plans on the Health Insurance Marketplace.
Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.
External Relationships
- Cardinal Health, Inc.
- Curio Science LLC
- MJH Healthcare holdings